IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

General Catalyst Group Management, LLC

Q1 2026 Holdings

Filed 2026-05-15 | 12 holdings | $183.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Samsara Inc(IOT)COM CL A79589L106$63.4M2,000,00034.5%
Arrivent Biopharma Inc(AVBP)COM04272N102$34.5M1,494,78618.8%
Maze Therapeutics Inc(MAZE)COM578784100$30.9M1,035,91016.8%
Maplebear Inc(CART)COM565394103$26.6M710,71114.5%
Gitlab Inc(GTLB)CLASS A COM37637K108$19.9M921,40510.9%
Eikon Therapeutics Inc(EIKN)COM282564103$3.2M305,2331.8%
Fractyl Health Inc(GUTS)COM35168W103$2.2M4,884,1931.2%
Ethos Technologies Inc(LIFE)CL A29765A101$828.6K74,1790.5%
Coupang Inc(CPNG)CL A22266T109$692.5K36,6770.4%
Amazon COM Inc(AMZN)COM023135106$537.8K2,5820.3%
Meta Platforms Inc(META)CL A30303M102$376.5K6580.2%
Figma Inc(FIG)CLASS A COM STK316841105$313.8K14,8450.2%